These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 1974512

  • 1. The role of multiple action agents in hypertension.
    Lund-Johansen P, Omvik P.
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S89-95. PubMed ID: 1974512
    [Abstract] [Full Text] [Related]

  • 2. Essential hypertension: hemodynamic and therapeutic changes over 20 years.
    Lund-Johansen P.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S1-7. PubMed ID: 1721971
    [Abstract] [Full Text] [Related]

  • 3. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW, Laugerotte A, Wright JM.
    Cochrane Database Syst Rev; 2015 Aug 26; 2015(8):CD007449. PubMed ID: 26306578
    [Abstract] [Full Text] [Related]

  • 4. Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
    Omvik P, Lund-Johansen P.
    Cardiovasc Drugs Ther; 1993 Apr 26; 7(2):193-206. PubMed ID: 8395198
    [Abstract] [Full Text] [Related]

  • 5. Long-term hemodynamic effects of antihypertensive treatment.
    Lund-Johansen P, Omvik P, Nordrehaug JE.
    Clin Investig; 1992 Apr 26; 70 Suppl 1():S58-64. PubMed ID: 1350486
    [Abstract] [Full Text] [Related]

  • 6. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P, Omvik P, Nordrehaug JE, White W.
    J Cardiovasc Pharmacol; 1992 Apr 26; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of carvedilol on atrial natriuretic peptide, catecholamines, and hemodynamics in hypertension at rest and during exercise.
    Omvik P, Lund-Johansen P, Myking O.
    J Cardiovasc Pharmacol; 1992 Apr 26; 19 Suppl 1():S90-6. PubMed ID: 1378157
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension.
    Lund-Johansen P.
    Clin Nephrol; 1992 Apr 26; 38 Suppl 1():S78-86. PubMed ID: 1363538
    [Abstract] [Full Text] [Related]

  • 11. Carvedilol in hypertension treatment.
    Stafylas PC, Sarafidis PA.
    Vasc Health Risk Manag; 2008 Apr 26; 4(1):23-30. PubMed ID: 18629377
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamic effects of beta-blocking compounds possessing vasodilating activity: a review of labetalol, prizidilol, and dilevalol.
    Lund-Johansen P.
    J Cardiovasc Pharmacol; 1988 Apr 26; 11 Suppl 2():S12-7. PubMed ID: 2464093
    [Abstract] [Full Text] [Related]

  • 13. Age hemodynamics and exercise in essential hypertension: difference between beta-blockers and dihydropyridine calcium antagonists.
    Lund-Johansen P.
    J Cardiovasc Pharmacol; 1989 Apr 26; 14 Suppl 10():S7-13. PubMed ID: 2483573
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Acute hemodynamic effects of carvedilol in comparison with propranolol in patients with coronary heart disease.
    Wendt T.
    Clin Investig; 1992 Apr 26; 70 Suppl 1():S93-7. PubMed ID: 1350491
    [Abstract] [Full Text] [Related]

  • 17. Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule.
    Strein K, Sponer G.
    Z Kardiol; 1990 Apr 26; 79 Suppl 3():89-98. PubMed ID: 1983054
    [Abstract] [Full Text] [Related]

  • 18. Hemodynamic effects of carvedilol after acute oral administration in hypertensive and normal subjects.
    Cournot A, Lim C, Duchier J, Safar M.
    J Cardiovasc Pharmacol; 1992 Apr 26; 19 Suppl 1():S35-9. PubMed ID: 1378147
    [Abstract] [Full Text] [Related]

  • 19. Protective effects of carvedilol, a vasodilating beta-adrenoceptor blocker, against in vivo low density lipoprotein oxidation in essential hypertension.
    Maggi E, Marchesi E, Covini D, Negro C, Perani G, Bellomo G.
    J Cardiovasc Pharmacol; 1996 Apr 26; 27(4):532-8. PubMed ID: 8847870
    [Abstract] [Full Text] [Related]

  • 20. Acute haemodynamic effects of carvedilol in essential hypertension at rest and during exercise.
    Omvik P, Lund-Johansen P.
    Eur Heart J; 1991 Jun 26; 12(6):736-40. PubMed ID: 1860471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.